Skip to content
CheckOrphan
  • Home
  • About Us
  • Log In
  • News
    • All News
    • Finance
    • Treatment
    • People
  • Videos
  • Treatments
  • Clinical Trials
  • Access Programs
    • About Access Programs
  • Diseases
  • Events
  • Networks
  • Research
Main Menu

Subscribe for Free Newsletter

Email *

Type *

Warning: foreach() argument must be of type array|object, null given in /var/www/wordpress/wp-content/themes/awaken-child/single-newsletter.php on line 54

* Required Field
Email Marketing Services by Benchmark

Generate RSS

  1. Home
  2. /
  3. Disease
  4. /
  5. Gestational Trophoblastic Neoplasms

Gestational Trophoblastic Neoplasms

December 31, 2014

Related Clinical Trial

  • A Feasibility Window Study of Pembrolizumab Prior to Second Evacuation
  • Dostarlimab in Chemoresistant Gestational Trophoblastic Neoplasia
  • Letrozole as a Prophylaxis From GTN for Complete Mole Patients
  • Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trop
  • Study of PD-1 Antibody and Bevacizumab in the Treatment of High-risk G
More Clinical Trial

Latest Research

  • "More than a song and dance": Exploration of patient perspectives and educational quality of gynecologic cancer content on TikTok
  • A case of complete remission of intractable gestational choriocarcinoma with subsequent chemotherapy after pembrolizumab
  • A Metastatic Invasive Mole in a Perimenopausal Woman: A Rare Case
  • A phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609 Cohort 47) in patients with gestational trophoblastic neoplasia
  • Acute pulmonary complications in the setting of high risk gestational trophoblastic neoplasia and induction of chemotherapy
More Research
pw

About CheckOrphan

CheckOrphan is a non-profit organization located in Basel, Switzerland and Santa Cruz, California that is dedicated to rare, orphan and neglected diseases. CheckOrphan offers users an interactive and dynamic platform for all these diseases. This strategy allows visitors to be updated daily on all the latest news and interact with people internationally. This is essential, because due to the nature of these diseases, there is not a large concentration of individuals within any given proximity.
Click here to know more About Us

Your email is important to us

Each email is sent to a CheckOrphan staff member and will be answered. We only use a contact form to avoid spam.

    Copyright © 2023 CheckOrphan.
    Developed by: Gonza.io logo Developed by: WebOptimalSolutions Powered by: Cloudscale logo